Drugs / INXN-2001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01397708 | Aug 2011 → Sep 2014 | melanoma | Alaunos Therapeutics | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | INXN-2001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01397708 ↗ |